Sample size calculation based on efficient unconditional tests for clinical trials with historical controls

被引:9
|
作者
Shan, Guogen [1 ]
Moonie, Sheniz [1 ]
Shen, Jay [2 ]
机构
[1] Univ Nevada, Sch Community Hlth Sci, Epidemiol & Biostat Program, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA
[2] Univ Nevada, Sch Community Hlth Sci, Dept Hlth Care Adm & Policy, Las Vegas, NV 89154 USA
关键词
Exact test; E plus M approach; historical clinical trial; sample size; unconditional test; BINARY MATCHED-PAIRS; PHASE-II; P-VALUES; BINOMIAL PROPORTIONS; DETECTING TRENDS; STATISTICS; POWER;
D O I
10.1080/10543406.2014.1000545
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In historical clinical trials, the sample size and the number of success in the control group are often considered as given. The traditional method for sample size calculation is based on an asymptotic approach developed by Makuch and Simon (1980). Exact unconditional approaches may be considered as alternative to control for the type I error rate where the asymptotic approach may fail to do so. We provide the sample size calculation using an efficient exact unconditional testing procedure based on estimation and maximization. The sample size using the exact unconditional approach based on estimation and maximization is generally smaller than those based on the other approaches.
引用
收藏
页码:240 / 249
页数:10
相关论文
共 50 条
  • [21] Inference and sample size calculation for clinical trials with incomplete observations of paired binary outcomes
    Zhang, Song
    Cao, Jing
    Ahn, Chul
    STATISTICS IN MEDICINE, 2017, 36 (04) : 581 - 591
  • [22] On Sample Size and Power Calculation for Variant Set-Based Association Tests
    Wu, Baolin
    Pankow, James S.
    ANNALS OF HUMAN GENETICS, 2016, 80 (02) : 136 - 143
  • [23] Sample Size Calculation for Clinical Trials of Medical Decision Support Systems with Binary Outcome
    Rebrova, O. Yu.
    Gusev, A. V.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2022, 14 (03) : 6 - 13
  • [24] Sample size justification in phase III/IV clinical trials
    Richardson, D
    Leurgans, S
    NEUROEPIDEMIOLOGY, 1998, 17 (02) : 63 - 66
  • [25] Considerations on sample size and power calculations in randomized clinical trials
    Karlsson, J
    Engebretsen, L
    Dainty, K
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2003, 19 (09) : 997 - 999
  • [26] Sample size calculation for stepped wedge and other longitudinal cluster randomised trials
    Hooper, Richard
    Teerenstra, Steven
    de Hoop, Esther
    Eldridge, Sandra
    STATISTICS IN MEDICINE, 2016, 35 (26) : 4718 - 4728
  • [27] Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls
    Yuan, Jiacheng
    Liu, Jeen
    Zhu, Ray
    Lu, Ying
    Palm, Ulo
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (03) : 558 - 573
  • [28] An introduction to sample size calculations in clinical trials
    Accordini, Simone
    EPIDEMIOLOGIA E PSICHIATRIA SOCIALE-AN INTERNATIONAL JOURNAL FOR EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2007, 16 (04): : 299 - 301
  • [29] Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases
    van der Lee, J. H.
    Wesseling, J.
    Tanck, M. W. T.
    Offringa, M.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (04) : 324 - 330
  • [30] Considering Over-Dispersion in the Sample Size Calculation for Clinical Trials With Repeated Count Measurements
    Li, Dateng
    Cao, Jing
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2019, 11 (03): : 283 - 291